프로바이오틱스 시장 : 예측(2025-2030년)

Probiotics Market Size:

The Probiotics Market is expected to grow from USD 98.585 billion in 2025 to USD 170.507 billion in 2030, at a CAGR of 11.58%.

The probiotics market encompasses live bacteria and yeasts that provide health benefits to humans and animals, particularly through digestive system improvement. These beneficial microorganisms strengthen immune systems, reduce intestinal inflammation, improve gut health, and protect against oxidative destruction of proteins and lipids while reducing pathogenic organisms in the body.

Market Foundation and Health Applications

Probiotics demonstrate therapeutic potential across multiple health conditions, extending beyond traditional digestive applications into mental health and neurological disorder management. The gut-brain connection research supports probiotic applications in addressing mental health conditions, which have experienced significant global prevalence increases over recent years according to health organizations.

The technology's expanding therapeutic scope includes diagnosis and treatment support for various neurological disorders, representing a growing application area that extends probiotic utility beyond conventional digestive health benefits. This diversification creates new market opportunities while supporting broader healthcare applications.

Primary Market Growth Drivers

Increasing health awareness represents the fundamental driver of market expansion, as consumers actively seek healthy food products for daily consumption. The growing understanding of diet-health relationships drives demand for probiotic-enhanced foods, beverages, and dietary supplements that provide both basic nutrition and health enhancement benefits.

Demographic changes including aging populations, particularly in developing economies, create sustained demand for health-supporting products. Rising disposable income levels and lifestyle changes support premium product adoption, while changing food consumption patterns drive probiotic integration into daily dietary routines.

The fitness and wellness trend among younger global populations drives notable growth in the dietary supplements segment. Health-conscious consumers increasingly incorporate probiotics into fitness regimens and general wellness strategies, creating sustained market demand for specialized formulations.

Product innovation expansion into diverse categories including chocolates, biscuits, beverages, and various food products broadens market accessibility and consumer adoption opportunities. These innovations provide multiple consumption options that cater to different preferences and lifestyle requirements.

Application Segmentation and Market Distribution

The functional food and beverages segment maintains significant market share through rising processed food consumption, poor lifestyle patterns, and increased nutritional education from health authorities and media. This segment benefits from convenient integration into existing dietary habits while providing health benefits.

Animal feed applications demonstrate substantial growth potential driven by changing dietary patterns leading to increased meat consumption, especially in developing economies. Probiotics in animal husbandry ensure proper animal health while addressing disease outbreak concerns, supporting meat quality and production efficiency.

The dietary supplements segment experiences notable growth through fitness awareness and health consciousness, particularly among younger demographics. Advanced probiotic strain development for specific health purposes further accelerates market expansion in this segment.

Geographic Market Analysis

The Asia Pacific region demonstrates significant growth potential through increasing demand from developing countries including India and China. Rapidly expanding populations, rising disposable income, and growing health benefit awareness drive market expansion. Established brands like Yakult successfully penetrate regional markets, supporting overall category development.

North America represents substantial growth opportunities through significant manufacturer investments in cosmetic and pharmaceutical industry applications. The region's advanced research infrastructure and consumer health awareness support premium product adoption and innovation development.

Strain Types and Ingredient Analysis

Lactobacillus and Bifidobacterium represent the most commonly used non-spore-forming probiotics in food and feed applications globally. These strains demonstrate proven efficacy in dairy products, improving lactose tolerance and pathogenic bacteria resistance while supporting overall gut health.

The bacteria segment maintains dominant market share through extensive health benefits including increased lactase production, diarrhea prevention, immune system disorder prevention, and enhanced Lactobacilli immunity. Additional microorganisms including Saccharomyces cerevisiae, Escherichia coli, and Enterococci provide specialized applications.

Market Constraints and Investment Challenges

High research and development costs present significant barriers to market entry and product development. Laboratory development, research equipment procurement, and trained professional recruitment require substantial initial investments that may not generate immediate returns due to the health-focused nature of probiotic products.

Established market players including Chr. Hansen, Danone, Yakult, and Nestle have implemented comprehensive R&D strategies that create competitive barriers for new entrants. The capital-intensive nature of probiotic strain development and testing limits market participation to well-funded organizations.

Competitive Landscape and Strategic Developments

Major market participants include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Probi AB, Lifeway Foods, BioGaia, Mother Dairy Fruit and Vegetable Pvt. Ltd., Arla Foods AMBA, i-Health, Inc., and Chr. Hansen Holding A/S. These companies implement diverse growth strategies including product development, strategic partnerships, and market expansion initiatives.

Strategic Industry Implications

For nutraceutical industry professionals, the probiotics market represents opportunities at the intersection of functional foods, dietary supplements, and therapeutic applications. Success requires balancing innovation investment with market accessibility while addressing diverse consumer needs across food, supplement, and specialized health applications.

Market evolution toward mental health applications and advanced strain development suggests opportunities for companies developing targeted probiotic solutions that address specific health conditions while maintaining broad consumer appeal through accessible product formats.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Probiotics Market Segmentation:

By Ingredients

• Bacteria
• Yeast

By Function

• Regular
• Preventive Healthcare
• Therapeutic

By Type

• Lactobacillus
• Streptococcus
• Bifidobacterium
• Spore Formers
• Others

By Application

• Functional food and beverages
• Dietary supplements
• Animal Feed

By End-User

• Human Probiotics
• Animal Probiotics

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PROBIOTICS MARKET BY INGREDIENTS

• 5.1. Introduction
• 5.2. Bacteria
• 5.3. Yeast

6. PROBIOTICS MARKET BY FUNCTION

• 6.1. Introduction
• 6.2. Regular
• 6.3. Preventive Healthcare
• 6.4. Therapeutic

7. PROBIOTICS MARKET BY TYPE

• 7.1. Introduction
• 7.2. Lactobacillus
• 7.3. Streptococcus
• 7.4. Bifidobacterium
• 7.5. Spore Formers
• 7.6. Others

8. PROBIOTICS MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Functional food and beverages
• 8.3. Dietary supplements
• 8.4. Animal Feed

9. PROBIOTICS MARKET BY END-USER

• 9.1. Introduction
• 9.2. Human Probiotics
• 9.3. Animal Probiotics

10. PROBIOTICS MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. By Ingredients
  • 10.2.2. By Function
  • 10.2.3. By Type
  • 10.2.4. By Application
  • 10.2.5. By End-User
  • 10.2.6. By Country
    • 10.2.6.1. USA
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. South America
  • 10.3.1. By Ingredients
  • 10.3.2. By Function
  • 10.3.3. By Type
  • 10.3.4. By Application
  • 10.3.5. By End-User
  • 10.3.6. By Country
    • 10.3.6.1. Brazil
    • 10.3.6.2. Argentina
    • 10.3.6.3. Others
• 10.4. Europe
  • 10.4.1. By Ingredients
  • 10.4.2. By Function
  • 10.4.3. By Type
  • 10.4.4. By Application
  • 10.4.5. By End-User
  • 10.4.6. By Country
    • 10.4.6.1. United Kingdom
    • 10.4.6.2. Germany
    • 10.4.6.3. France
    • 10.4.6.4. Spain
    • 10.4.6.5. Others
• 10.5. Middle East and Africa
  • 10.5.1. By Ingredients
  • 10.5.2. By Function
  • 10.5.3. By Type
  • 10.5.4. By Application
  • 10.5.5. By End-User
  • 10.5.6. By Country
    • 10.5.6.1. Saudi Arabia
    • 10.5.6.2. UAE
    • 10.5.6.3. Others
• 10.6. Asia Pacific
  • 10.6.1. By Ingredients
  • 10.6.2. By Function
  • 10.6.3. By Type
  • 10.6.4. By Application
  • 10.6.5. By End-User
  • 10.6.6. By Country
    • 10.6.6.1. China
    • 10.6.6.2. Japan
    • 10.6.6.3. India
    • 10.6.6.4. South Korea
    • 10.6.6.5. Taiwan
    • 10.6.6.6. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. Yakult Honsha Co., Ltd.
• 12.2. Danone S.A
• 12.3. Nestle S.A
• 12.4. Probi AB
• 12.5. Lifeway Foods
• 12.6. BioGaia
• 12.7. Mother Dairy Fruit and Vegetable Pvt. Ltd.
• 12.8. Arla Foods AMBA
• 12.9. i-Health, Inc.,
• 12.10. Chr. Hansen Holding A/S

13. APPENDIX

• 13.1. Currency
• 13.2. Assumptions
• 13.3. Base and Forecast Years Timeline
• 13.4. Key benefits for the stakeholders
• 13.5. Research Methodology
• 13.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES